What could your Bristol-Myers Squibb investment become?

Is Bristol-Myers Squibb a dividend stock?

Yes — Bristol-Myers Squibb (BMY) pays a dividend yield of 5%, paid quarterly. It pays out about 75% of its earnings as dividends, a relatively high share that prioritises income for shareholders.

Bristol-Myers Squibb pays dividends quarterly, so investors receive income quarterly.

What sector is Bristol-Myers Squibb in?

Bristol-Myers Squibb (BMY) is part of the Healthcare sector. Healthcare covers pharmaceuticals, medical devices, and health services. Demand tends to hold up across economic cycles because people need care in good times and bad. Bristol-Myers Squibb trades at a price-to-earnings (P/E) ratio of around 16, which reflects how much investors are currently willing to pay for each dollar of the company's earnings.

💡 Cancer and cardiovascular drugs.

⚡ Eliquis (anticoagulant) is one of the world's top-selling drugs.

How is this projection calculated?

The calculator above assumes a 6% average annual return — roughly in line with long-term stock-market averages — and compounds your investment year by year. Dividend income is estimated from Bristol-Myers Squibb's current 5% yield. These are educational projections based on historical averages. Actual returns may vary, and your capital is at risk.